Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| Sep 10 | ROIV | Roivant Sciences Ltd. | FTAX | 2,905 | $40.94 | $118.9K | -2.6% | Open the original filing on SEC.gov |
| Jul 17 | ROIV | Roivant Sciences Ltd. | AGRANT | 405 | — | — | +0.4% | Open the original filing on SEC.gov |
| Jun 22 | BBIO | BridgeBio Pharma, Inc. | AGRANT◆ | 5,277 | — | — | — | Open the original filing on SEC.gov |
| Jun 22 | BBIO | BridgeBio Pharma, Inc. | AGRANT | 3,990 | — | — | +26.5% | Open the original filing on SEC.gov |
| Apr 17 | ROIV | Roivant Sciences Ltd. | FTAX | 94 | $29.83 | $2.8K | <0.1% | Open the original filing on SEC.gov |
| Apr 17 | ROIV | Roivant Sciences Ltd. | AGRANT | 469 | — | — | +0.4% | Open the original filing on SEC.gov |
| Jan 20 | ROIV | Roivant Sciences Ltd. | FTAX | 122 | $22.98 | $2.8K | -0.1% | Open the original filing on SEC.gov |
| Jan 20 | ROIV | Roivant Sciences Ltd. | AGRANT | 609 | — | — | +0.6% | Open the original filing on SEC.gov |
| Oct 20, 2025 | ROIV | Roivant Sciences Ltd. | FTAX | 158 | $17.74 | $2.8K | -0.1% | Open the original filing on SEC.gov |
| Oct 20, 2025 | ROIV | Roivant Sciences Ltd. | AGRANT | 789 | — | — | +0.7% | Open the original filing on SEC.gov |
| Sep 10, 2025 | ROIV | Roivant Sciences Ltd. | AGRANT◆ | 33,726 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | ROIV | Roivant Sciences Ltd. | JOTHER | 3,282 | $13.77 | $45.2K | -2.9% | Open the original filing on SEC.gov |
| Sep 10, 2025 | ROIV | Roivant Sciences Ltd. | AGRANT | 14,524 | — | — | +15.0% | Open the original filing on SEC.gov |
| Jul 17, 2025 | ROIV | Roivant Sciences Ltd. | FTAX | 241 | $11.65 | $2.8K | -0.3% | Open the original filing on SEC.gov |
| Jul 17, 2025 | ROIV | Roivant Sciences Ltd. | AGRANT | 1,201 | — | — | +1.3% | Open the original filing on SEC.gov |
| Jun 20, 2025 | BBIO | BridgeBio Pharma, Inc. | AGRANT◆ | 8,425 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | BBIO | BridgeBio Pharma, Inc. | AGRANT | 6,589 | — | — | +7.4% | Open the original filing on SEC.gov |
| Apr 17, 2025 | ROIV | Roivant Sciences Ltd. | FTAX | 276 | $10.15 | $2.8K | -0.3% | Open the original filing on SEC.gov |
| Apr 17, 2025 | ROIV | Roivant Sciences Ltd. | AGRANT | 1,379 | — | — | +1.5% | Open the original filing on SEC.gov |